HIMS Latest Headlines

Hims adds injectable and oral TRT options as its biggest men’s health expansion since last September

Market Chameleon (Wed, 21-Oct 9:02 AM)

Hims & Hers Sets Nov. 9 Earnings Date, with a 5:00 p.m. ET Conference Call

Market Chameleon (Tue, 13-Oct 7:34 AM)

Rosen Law Firm Highlights Nov. 2 Lead-Plaintiff Deadline for Hims Investors Covering Aug. 2025–Jul. 2026 Class Period

Market Chameleon (Fri, 9-Oct 11:50 AM)

Hims & Hers taps ex-Rivian controller Jon Franklin as Chief Accounting Officer as it pushes into new specialties and global markets

Market Chameleon (Thu, 8-Oct 7:12 AM)

Hims & Hers investor deadline spotlights FTC-linked allegations and a November 2, 2026 lead-plaintiff window

Market Chameleon (Fri, 18-Sep 10:42 AM)

Hims & Hers Unveils First Doctor-Led AI Care Journey for Women—App and Smart Scale Set New Standard

Market Chameleon (Thu, 6-Aug 9:15 AM)